Trial · NCT01723722
Treatment of Neonatal Abstinence Syndrome
NCT01723722, Phase 4, Completed, Eastern Maine Medical Center; results first posted 2013-11-27
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of Neonatal Abstinence Syndrome. Trials, record NCT01723722. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01723722
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of Neonatal Abstinence Syndrome
- NCT number
- NCT01723722
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 40 participants, actual
- Lead sponsor
- Eastern Maine Medical Center
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Methadone, Diluted Deodorized Tincture of Opium
- First posted
- 2012-11-08
- Last updated
- 2013-11-27
- Results first posted
- 2013-11-27
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Length of Treatment With Opioid Medication | Up to 12 months | Up to 12 months |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Length of Treatment With Opioid Medication | Up to 12 months | Completion of treatment | days | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Length of Treatment With Opioid Medication | Deodorized Tincture Opium After Phenobarbital for Withdrawal | 19.1 | Standard Deviation 8.8 | days | |
| Length of Treatment With Opioid Medication | Methadone After Phenobarbital for Withdrawal | 17.7 | Standard Deviation 10 | days |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Methadone After Phenobarbital for Withdrawal | 20 | |
| Overall Study | STARTED | Deodorized Tincture Opium After Phenobarbital for Withdrawal | 20 | |
| Overall Study | COMPLETED | Methadone After Phenobarbital for Withdrawal | 20 | |
| Overall Study | COMPLETED | Deodorized Tincture Opium After Phenobarbital for Withdrawal | 20 | |
| Overall Study | NOT COMPLETED | Methadone After Phenobarbital for Withdrawal | 0 | |
| Overall Study | NOT COMPLETED | Deodorized Tincture Opium After Phenobarbital for Withdrawal | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Methadone After Phenobarbital for Withdrawal | ||
| Total, all-cause mortality | DTO After Phenobarbital for Withdrawal | ||
| Total, other adverse events | Methadone After Phenobarbital for Withdrawal | 0 | 20 |
| Total, other adverse events | DTO After Phenobarbital for Withdrawal | 0 | 20 |
| Total, serious adverse events | Methadone After Phenobarbital for Withdrawal | 0 | 20 |
| Total, serious adverse events | DTO After Phenobarbital for Withdrawal | 0 | 20 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34231914 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Methadone After Phenobarbital for Withdrawal vs DTO After Phenobarbital for Withdrawal: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01723722
GET https://conductscience.org/api/trials/v1/NCT01723722/registered